DGX vs NEPH · P/E 22, rev $5.94B vs P/E 48, rev $11.2M
Quest Diagnostics Incorporated (DGX) versus Nephros Inc (NEPH) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported NEPH revenue for 2026-06-30 was $11.2M. Net income was $1.3M. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
Not investment advice. Open the DGX and NEPH stock pages for the full models.
Not investment advice.